동물용 의약품 시장 : 제품 유형, 투여 방법, 동물 유형, 유통 채널, 최종사용자별 - 세계 예측(2025-2030년)

The Veterinary Medicine Market was valued at USD 42.34 billion in 2023, expected to reach USD 45.51 billion in 2024, and is projected to grow at a CAGR of 7.69%, to USD 71.16 billion by 2030.

The veterinary medicine market encompasses pharmaceuticals, vaccines, diagnostic tools, and medical devices aimed at treating and monitoring the health of animals. Its necessity arises from the growing demand for pet ownership, increased focus on livestock health for food safety, and the rising incidence of zoonotic diseases. Applications span from preventive care and disease treatment in companion animals to maintaining herd health in livestock. End-use sectors include veterinary hospitals, clinics, and animal research institutes. Market growth is influenced by factors such as the increasing pet population and adoption rates, technological advancements in veterinary healthcare, and heightened awareness regarding animal health. Opportunities lie in the surge of pet insurance, coupled with the increasing spend on pet healthcare, which could lead to more investment in innovative treatments and technology. Countries with growing economies offer untapped markets due to the rising disposable income which fosters pet adoption. Also, the advancement in biotechnology enables the development of precision medicine tailored for veterinary use. However, the market faces limitations such as stringent regulatory environments, high development costs for new drugs, and the challenge of antibiotic resistance. Additionally, varying pet healthcare awareness across regions poses a challenge in market penetration. Areas ripe for innovation include telemedicine for veterinary care, AI-driven diagnostic tools, and personalized medicine using genomic data. Furthermore, research into alternative therapies and eco-friendly veterinary products presents a promising avenue for growth. The veterinary medicine market is dynamic and competitive, driven by rapid technological advancements and evolving consumer expectations. Companies that invest in R&D to innovate solutions addressing these new demands, while navigating regulatory and economic hurdles, stand to gain a competitive edge. Strategic partnerships and collaborations can further bolster market presence and adaptability in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Medicine Market

The Veterinary Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid growth in global livestock population due to rising demand for meat and dairy production
  • Rise in pet adoption rates
  • Increasing cases of zoonotic and chronic diseases
• Market Restraints
  • High influx of counterfeit drugs
• Market Opportunities
  • Rising R&D and procedural advancements in vet medicine
  • Rising spending on pet care in urban areas
• Market Challenges
  • Short product exclusivity period

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Medicine Market

A detailed market share analysis in the Veterinary Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Medicine Market, highlighting leading vendors and their innovative profiles. These include C. H. Boehringer Sohn AG & Co. KG, Archer-Daniels-Midland Company, Biopharm company, Neogen Corporation, Biogenesis Bago SA, Merck & Co. Inc., Biowet Pulawy sp. z o.o., Zoetis Inc., Phibro Animal Health Corporation, Intracin Pharmaceutical Private Limited, Brovapharma, JoinHub Pharma, Virbac SA, Dechra Pharmaceuticals PLC, Nam Pharma Sdn Bhd, Vetpharma Animal Health S.L., Indian Immunologicals Ltd, Vetoquinol S.A., TRAVETCO, Hester Biosciences Limited, Nutreco N.V., Vetsintez LLC, Ceva Sante Animale, Elanco Animal Health Incorporated, Weefsel Pharma, Evonik Industries AG, NAPHAVET Co., Ltd., and Sykes Vet International Pty Ltd..

Market Segmentation & Coverage

This research report categorizes the Veterinary Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biologics, Medicated Feed Additives, and Pharmaceuticals. The Biologics is further studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, and Recombinant Vaccines. The Pharmaceuticals is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
• Based on Mode of Delivery, market is studied across Injectable, Oral, and Topical.
• Based on Animal Type, market is studied across Companion and Production. The Companion is further studied across Cats, Dogs, and Horses. The Production is further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine.
• Based on Distribution Channels, market is studied across Hospital/Retail Pharmacies and Online Marketplace.
• Based on End-user, market is studied across Households/Farms and Veterinary Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid growth in global livestock population due to rising demand for meat and dairy production
    • 5.1.1.2. Rise in pet adoption rates
    • 5.1.1.3. Increasing cases of zoonotic and chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High influx of counterfeit drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D and procedural advancements in vet medicine
    • 5.1.3.2. Rising spending on pet care in urban areas
  • 5.1.4. Challenges
    • 5.1.4.1. Short product exclusivity period
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for biologics to manage diseases in animals
  • 5.2.2. End-user: Expanding usage of veterinary medicines at veterinary hospitals and clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Veterinary Medicine Market, by Product

• 6.1. Introduction
• 6.2. Biologics
  • 6.2.1. DNA Vaccines
  • 6.2.2. Inactivated Vaccines
  • 6.2.3. Live Attenuated Vaccines
  • 6.2.4. Recombinant Vaccines
• 6.3. Medicated Feed Additives
• 6.4. Pharmaceuticals
  • 6.4.1. Analgesics
  • 6.4.2. Anti-infectives
  • 6.4.3. Anti-inflammatory
  • 6.4.4. Parasiticides

7. Veterinary Medicine Market, by Mode of Delivery

• 7.1. Introduction
• 7.2. Injectable
• 7.3. Oral
• 7.4. Topical

8. Veterinary Medicine Market, by Animal Type

• 8.1. Introduction
• 8.2. Companion
  • 8.2.1. Cats
  • 8.2.2. Dogs
  • 8.2.3. Horses
• 8.3. Production
  • 8.3.1. Cattle
  • 8.3.2. Fish
  • 8.3.3. Poultry
  • 8.3.4. Sheep & Goats
  • 8.3.5. Swine

9. Veterinary Medicine Market, by Distribution Channels

• 9.1. Introduction
• 9.2. Hospital/Retail Pharmacies
• 9.3. Online Marketplace

10. Veterinary Medicine Market, by End-user

• 10.1. Introduction
• 10.2. Households/Farms
• 10.3. Veterinary Hospitals & Clinics

11. Americas Veterinary Medicine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Veterinary Medicine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Medicine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. ENTOD Pharmaceuticals Expands Global Reach with FUR Division, Offering Advanced Eye and Ear Care for Pets
  • 14.3.2. FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
  • 14.3.3. Zoetis officially launches 2 FDA approved drugs in the US veterinary market

Companies Mentioned

• 1. C. H. Boehringer Sohn AG & Co. KG
• 2. Archer-Daniels-Midland Company
• 3. Biopharm company
• 4. Neogen Corporation
• 5. Biogenesis Bago SA
• 6. Merck & Co. Inc.
• 7. Biowet Pulawy sp. z o.o.
• 8. Zoetis Inc.
• 9. Phibro Animal Health Corporation
• 10. Intracin Pharmaceutical Private Limited
• 11. Brovapharma
• 12. JoinHub Pharma
• 13. Virbac SA
• 14. Dechra Pharmaceuticals PLC
• 15. Nam Pharma Sdn Bhd
• 16. Vetpharma Animal Health S.L.
• 17. Indian Immunologicals Ltd
• 18. Vetoquinol S.A.
• 19. TRAVETCO
• 20. Hester Biosciences Limited
• 21. Nutreco N.V.
• 22. Vetsintez LLC
• 23. Ceva Sante Animale
• 24. Elanco Animal Health Incorporated
• 25. Weefsel Pharma
• 26. Evonik Industries AG
• 27. NAPHAVET Co., Ltd.
• 28. Sykes Vet International Pty Ltd.